201 related articles for article (PubMed ID: 37537694)
1. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract][Full Text] [Related]
2. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
3. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway.
Zhang Z; Wang H; Li M; Rayburn ER; Agrawal S; Zhang R
Oncogene; 2005 Nov; 24(48):7238-47. PubMed ID: 16170383
[TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of GSG2 in esophageal cancer progression.
Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
[TBL] [Abstract][Full Text] [Related]
6. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of
Yu W; Liu W; Feng Y; Zhu C
Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
[No Abstract] [Full Text] [Related]
9. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
10. NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1.
He J; Gao R; Yang J; Li F; Fu Y; Cui J; Liu X; Huang K; Guo Q; Zhou Z; Wei W
Cancer Sci; 2023 Mar; 114(3):896-907. PubMed ID: 35348268
[TBL] [Abstract][Full Text] [Related]
11. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
[TBL] [Abstract][Full Text] [Related]
12. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
13. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
Zhao X
Biomed Res Int; 2020; 2020():1480819. PubMed ID: 32733928
[TBL] [Abstract][Full Text] [Related]
14. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
15. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
[TBL] [Abstract][Full Text] [Related]
16. LOC100130075 Promotes Cervical Cancer Progression by Activating MDM2 Transcription through E2F1.
Xu Y; Liu Y; Huang W; Yang C; Wang Y
Reprod Sci; 2022 May; 29(5):1439-1448. PubMed ID: 35201567
[TBL] [Abstract][Full Text] [Related]
17. A functional SNP in the MDM2 promoter mediates E2F1 affinity to modulate cyclin D1 expression in tumor cell proliferation.
Yang ZH; Zhou CL; Zhu H; Li JH; He CD
Asian Pac J Cancer Prev; 2014; 15(8):3817-23. PubMed ID: 24870800
[TBL] [Abstract][Full Text] [Related]
18. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
Chen Y; Wang DD; Wu YP; Su D; Zhou TY; Gai RH; Fu YY; Zheng L; He QJ; Zhu H; Yang B
Br J Cancer; 2017 Oct; 117(8):1192-1201. PubMed ID: 28817834
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
Zhang D; Yang XJ; Luo QD; Xue L; Chong T
Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]